Chinmaya Rath

Chinmaya Rath currently serves as SVP and Chief Business Officer at GlycoMimetics since September 2022, while also holding positions such as Strategic Advisor, Entrepreneur In Residence at Catena Biosciences, and Board Observer at Menten AI. Additionally, Chinmaya is a Venture Partner at Social Impact Capital and a Non-Executive Board Director at mAbTree Biologics. Previous roles include Founder CEO at CelluRx, Strategic Advisor at SalioGen Therapeutics, and various leadership roles at Omega Therapeutics and AstraZeneca. An extensive career at Novartis involved oversight of US oncology strategy and marketing. Chinmaya holds an MBA in General Management from the University of Warwick and another MBA in Marketing and HRM from the Army Institute of Management & Technology, along with a BSc in Lifesciences from Ravenshaw University.